What Is Biotechnology?

NOT INTERESTED? [‘UNSUBSCRIBE’]( <--CLICK Investor Marketing designed for growth Greetings Investors, What Is Biotechnology? Biotechnology is a science-driven industry sector that uses living organisms and molecular biology to produce healthcare-related products. Biotechnology companies also develop therapeutics or processes (such as DNA fingerprinting). Biotechnology is best known for its role in medicine and pharmaceuticals.[i](#_edn1) Biotechnology in its basic form has existed for thousands of years, dating back to an era when humans first learned to produce bread, beer, and wine using the natural process of fermentation.[ii](#_edn2) Biotech Today The biotechnology sector has grown by leaps and bounds since the 1990s. The industry has spawned giant companies in the medical space such as Gilead Sciences, Amgen, Biogen Idec, and Celgene. At the other extreme are thousands of small, dynamic biotech companies, many of which are engaged in various areas of the medical industry, such as drug development, genomics, or proteomics while others are involved in areas like bioremediation, biofuels, and food products.[iii](#_edn3) In 2020, the biotech industry in the U.S. and Europe combined raised over 115 billion U.S. dollars in capital.[iv](#_edn4) Medical biotech revenues exceeding $150 billion annually.[v](#_edn5) A mental health crisis has sparked innovation within the biotechnology industry. A particularly flourishing branch of mental health treatment can be seen in the use of psychedelics. Integrating psychiatry and medical biotechnology by using biotechnological products such as Ketamine with the intent to provide better outcomes for mental health patients. Commonly prescribed treatments for clinical depression often come with the risk of adverse side effects. [vi](#_edn6) One such company that is offering an alternative to the traditional prescribed medication is Pasithea Therapeutics Corp. (KTTA). Their goal is to help patients enjoy their lives to their fullest According to a study published online with Pharmaceuticals, “Incidence of significant adverse effects produced by repeated parenteral ketamine administration for depression in a monitored setting is low, and that repeated parenteral ketamine represents a reasonably safe treatment modality.”[viii](#_edn8) Who is Pasithea Therapeutics Corp. (KTTA)? Pasithea Clinics are driven by the mission to provide innovative and effective treatments to their patients suffering with psychiatric disorders through interventional psychiatric treatments, backed by leading scientific research and data. Ketamine Treatment is a new, ground-breaking treatment that is shown to be highly effective in reducing symptoms of anxiety, depression and PTSD.[ix](#_edn9) As psychiatry and medical biotechnology integrate; its exciting to watch Pasithea Therapeutics Corp. (KTTA) pioneer through this evolving industry. --------------------------------------------------------------- [i](#_ednref1) [ii](#_ednref2) [iii](#_ednref3) [iv](#_ednref4) [v](#_ednref5) [vi](#_ednref6) [vii](#_ednref7) [viii](#_ednref8) [ix](#_ednref9) [Download the Pasithea Therapeutics Investor Report]( [Pasithea Therapeutics logo]( [A woman with a nurse looking at each other and smiling, The nurse is holding a tablet and pointing to it.] Pasithea Therapeutics Corp. (NASDAQ: KTTA), a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida. [Download the Investor Report now to learn more about this opportunity.]( [DOWNLOAD THE REPORT]( No longer want to receive these emails? [Unsubscribe](. TradigitalIR 12 E 49th Street, 11th Fl. New York, NY 10017 This Website Is Wholly Owned By Tradigital Marketing Group, Inc. (D/B/A “Tradigital Ir”). Our Reports Are Advertorials And Are For General Information Purposes Only. Never Invest In Any Stock Featured On Our Site Or Emails Unless You Can Afford To Lose Your Entire Investment. The Disclaimer Is To Be Read And Fully Understood Before Using Our Services, Joining Our Email List, As Well As Any Social Networking Platforms We May Use. Please Note Well: Tradigital Ir And Its Employees Are Not Registered Investment Advisors, Broker-Dealers, Or Member(S) Of Any Association For Other Research Providers In Any Jurisdiction Whatsoever. Release Of Liability: Through Use Of This Website, Viewing Or Using You Agree To Hold Tradigital Ir, Its Operators, Owners, And Employees Harmless And To Completely Release Them From Any And All Liability Due To Any And All Loss (Monetary Or Otherwise), Damage (Monetary Or Otherwise), Or Injury (Monetary Or Otherwise) That You May Incur. The Information Contained Herein Is Based On Sources That We Believe To Be Reliable But Is Not Guaranteed By Us As Being Accurate And Does Not Purport To Be A Complete Statement Or Summary Of The Available Data. Tradigital Ir Encourages Readers And Investors To Supplement The Information In These Reports With Independent Research And Other Professional Advice. All Information On Featured Companies Is Provided By The Companies Profiled Or Is Available From Public Sources And Tradigital Ir Makes No Representations, Warranties, Or Guarantees As To The Accuracy Or Completeness Of The Disclosure By The Profiled Companies. None Of The Materials Or Advertisements Herein Constitute Offers Or Solicitations To Purchase Or Sell Securities Of The Companies Profiled Herein And Any Decision To Invest In Any Such Company Or Other Financial Decisions Should Not Be Made Based Upon The Information Provided Herein. Instead, Tradigital Ir Strongly Urges You To Conduct A Complete And Independent Investigation Of The Respective Companies And Consideration Of All Pertinent Risks. Tradigital Ir’s Full Disclosure Is To Be Read And Fully Understood Before Using Tradigital Ir's Website, Or Joining Tradigital Ir's Email Or Text List. From Time To Time, Tradigital Ir Will Disseminate Information About A Company Via Website, Email, Sms, And Other Points Of Media. By Viewing Tradigital Ir's Website And/Or Reading Tradigital Ir's Email Or Text Newsletter You Are Agreeing ----> [(. All Potential Percentage Gains Discussed In Any Communications Are Based On Calculations From The Low To The High Of The Day. We Are Engaged In The Business Of Marketing And Advertising Companies For Monetary Compensation. in Compliance With Section 17(B) Of The Securities Act We Are Disclosing That We have Been compensated A Fee Pursuant To An Agreement Between Tradigital And Pasithea Therapeutics Corp. Tradigital Was Hired For A Period Beginning January 2022 And Ending March 2022 To Publicly Disseminate Information About Pasithea Therapeutics Corp. Via Website, Email, And Sms. We Were Paid Five Hundred Forty-Four Thousand Usd Via Ach. We Own One Hundred Fifty Thousand Restricted Common Shares Of Pasithea Therapeutics Corp., Which Are Eligible For Sale On 03/18/2022. For The Purpose Of This Disclaimer, We Suggest That You Assume We Will Sell All Of Our Shares Once The Restriction Is Lifted On 03/18/2022. Readers Are Advised To Review Sec Periodic Reports: Forms 10-Q, 10k, Form 8-K, Insider Reports, Forms 3, 4, 5 Schedule 13d. Tradigital Ir Is Compliant With The Can-Spam Act Of 2003. Tradigital Ir Does Not Offer Investment Advice Or Analysis, And Tradigital Ir Further Urges You To Consult Your Own Independent Tax, Business, Financial, And Investment Advisors. Investing In Micro-Cap, Small-Cap, And Growth Securities Is Highly Speculative And Carries An Extremely High Degree Of Risk. It Is Possible That An Investors Investment May Be Lost Or Impaired Due To The Speculative Nature Of The Companies Profiled.The Private Securities Litigation Reform Act Of 1995 Provides Investors A Safe Harbor In Regard To Forward-Looking Statements. Any Statements That Express Or Involve Discussions With Respect To Predictions, Expectations, Beliefs, Plans, Projections, Objectives, Goals, Assumptions Or Future Events, Or Performance Are Not Statements Of Historical Fact May Be Forward-Looking Statements. Forward-Looking Statements Are Based On Expectations, Estimates, And Projections At The Time The Statements Are Made That Involve A Number Of Risks And Uncertainties Which Could Cause Actual Results Or Events To Differ Materially From Those Presently Anticipated. Forward-Looking Statements In This Action May Be Identified Through The Use Of Words Such As Projects, Foresee, Expects, Will, Anticipates, Estimates, Believes, Understands, Or That By Statements Indicating Certain Actions & Quotes; May, Could, Or Might Occur. Understand There Is No Guarantee Past Performance Will Be Indicative Of Future results In Preparing This Publication, Tradigital Ir Has Relied Upon Information Supplied By Its Clients, As Well As Its Clients’ Publicly Available Information And Press Releases Which It Believes To Be Reliable; However, Such Reliability Can Not Be Guaranteed. Investors Should Not Rely On The Information Contained On This Website. Rather, Investors Should Use The Information Contained In This Website As A Starting Point For Doing Additional Independent Research On The Featured Companies. The Advertisements In This Website Are Believed To Be Reliable, However, Tradigital Ir And Its Owners, Affiliates, Subsidiaries, Officers, Directors, Representatives, And Agents Disclaim Any Liability As To The Completeness Or Accuracy Of The Information Contained In Any Advertisement And For Any Omissions Of Materials Facts From Such Advertisement. Tradigital Ir Is Not Responsible For Any Claims Made By The Companies Advertised Herein, Nor Is Tradigital Ir Responsible For Any Other Promotional Firm, Its Program, Or Its Structure. tradigital Ir Is Not Affiliated With Any Exchange, Electronic Quotation System, The Securities Exchange Commission, Or Finra. ‌